Early studies identified markedly decreased expression of LFA‐1 as a CLL characteristic [115, 116], with an inverse correlation between LFA‐1 expression and the degree of leukocytosis [115]. Here, ITGB2 is linked to B-cell chronic lymphocytic leukemia.